Teprotumumab for Thyroid‐Associated Ophthalmopathy

Smith Terry J.; Kahaly G.; Ezra D.; Fleming J.; Dailey R.; Tang R.; Harris G.; Antonelli A.; Salvi M.; Goldberg R.; Gigantelli J.; Couch S.; Shriver E.; Hayek B.; Hink Eric M.; Woodward Richard; Gabriel K.; Magni G.; Douglas Raymond S.

doi:10.1056/nejmoa1614949

← Today's brief

Study

Teprotumumab for Thyroid‐Associated Ophthalmopathy

Smith Terry J. et al. · The New England Journal of Medicine · Sunday, January 1, 2017

Read original

Funding Not reported

Source

Smith Terry J. et al.. Teprotumumab for Thyroid‐Associated Ophthalmopathy The New England Journal of Medicine. Sunday, January 1, 2017.
doi:10.1056/nejmoa1614949

Generated, then checked claim-by-claim against the source · how this brief was built →

Physician-designed methodology · Amr Saad, MD MBA

Sign in to rate and bookmark articles

Automated evidence summary, checked against the source. Not medical advice. Verify with the original publication.